Welcome to EXIR PHARMACEUTICAL CO. WebSite
|
» NEWS
AND EVENTS |
|
|
|
The gathering was held from 24th August 2008 till 26th August in Tehran...
|
|
|
Welcome to EXIR PHARMACEUTICAL CO. WebSite
|
»
ARTICLE OF THE DAY |
|
|
|
Comparison of two treatment regimens in symptomaticaliy homogenous gerd patient
Populations : pantoprazole relieves gastrointestinal symptoms significantily better than omeprazole
|
|
|
|
Welcome to EXIR PHARMACEUTICAL CO. WebSite
|
»
EXIR PRODUCTS IN A GLANCE |
|
|
|
|
|
Welcome to EXIR PHARMACEUTICAL CO. WebSite
|
|
»
EXIR PRODUCTS
» Antidiabetics
|
|
|
|
|
| |
|
|
|
|
Insulin isophane (NPH) - Human-Exir |
|
|
|
|
Generic Name: |
|
|
Insulin isophane (NPH) - Human |
|
|
Dosage: |
|
|
100 IU/1ml,10 ml vial |
|
|
Lansulin® causes a fall in blood glucose concentration. It
facilitates glucose transport into cells and glucose metabolism
within them.
|
|
|
|
|
|
Metformin - Exir |
|
|
|
|
Generic Name: |
|
|
Metformin |
|
|
Dosage: |
|
|
500 mg F.C.Tab/100 s |
|
|
Metforex® reduces elevated blood glucose concentrations in patients with
diabetes, but it does not increase insulin secretion. There is no bloodglucose-
lowering effect in non-diabetic subjects. Augmentation of muscular
glucose uptake and utilization. and reduction of increased hepatic glucose
production through an antigluconeogenic action explain the blood-glucoselowering
effect. but the contribution of each of these processes to the
overall effect has not been defined. The intestinal glucose absorption may
be slightly delayed. Increased glucose utilization by the intestines and
erythrocytes results in increased lactate formation.The mechanism of
action involves binding of the apolar biguanide hydrocarbon side-chain
to membrane phospholipids, evoking a change in the electrostatic surface
potential.
|
|
|
|
|
|
|
|
|
|
|
Insulin (Regular) - Human - Exir |
|
|
|
|
Generic Name: |
|
|
Insulin (Regular) - Human |
|
|
Dosage: |
|
|
100 IU/1ml,10 ml vial |
|
|
Lansulin® causes a fall in blood glucose concentration. It
facilitates glucose transport into cells and glucose metabolism
within them. It inhibits ketogenesis and glycogenolysis, while
increasing lipid and glycogen synthesis. It reduces amino
acid release from skeletal muscle, and increases amino acid
transport into cells. It causes shifts of potassium and
magnesium from the extracellular fluid into cells.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
